Updated 25 September 2026.
INTC last quote: $127.39, up 3.91% against a prior close of $122.60, with a session range of $119.55 to $127.43 (Yahoo Finance, 25 September). Market cap $673.4 billion.
Verdict: Intel has run more than 300% off its 52-week low of $31.21 and now trades roughly 9% above Wall Street’s average 12-month target of $116.37. That is an unusual position: the consensus price target has become the bear case. The AI inference story is real, but the company is still loss-making on a trailing basis, and the stock is now ahead of the analysts who upgraded it.
Key facts
- Last quote: $127.39, against a prior close of $122.60. Session range $119.55 to $127.43.
- 52-week range: $31.21 to $142.35. The current price is about 308% above the low and roughly 10% below the high.
- Market cap: $673.4 billion.
- Trailing earnings: EPS of -$2.17, reflecting a trailing twelve-month net loss of about $11.29 billion. Forward P/E is 63.29.
- Consensus target: $116.37, which sits below the current share price.
- Most bullish named target: $145 from Tigress Financial, raised from $118 – but set when the stock was near $97.
- Live catalysts: AI inference demand tied to Meta’s Muse agent, reported PC processor price increases, and 18A process progress – against Apple further retiring Intel Mac support.
Why Intel is moving
The immediate driver is a reassessment of server CPU demand. Meta’s Muse AI agent topped the United States free iPhone app chart for three consecutive days following its launch, and consumer AI agents are inference workloads: they consume compute every time a user asks them to do something. KeyBanc’s Justin Patterson has flagged Muse’s distribution advantage as a structural factor rather than a launch-week spike.
That matters for Intel specifically because inference at scale is not purely a GPU story. A meaningful share of inference serving runs on general-purpose server CPUs, which is Intel’s Xeon franchise – the part of the business the market had largely written off during the accelerator boom. If agent adoption raises the baseline of server CPU demand, it changes the trajectory of Intel’s most profitable segment.
Two supporting data points have fed the same narrative. Intel has reportedly been raising PC processor prices by around 10%, which is the behaviour of a supplier that does not expect to lose the order. And on manufacturing, high-NA EUV is now in high-volume production with more than one million wafers run, with Intel 18A and Panther Lake layers reported at or above the performance of the prior 0.33 NA generation. After years in which Intel’s process roadmap was the reason to avoid the stock, that is a genuine change in the argument.
This is the same catalyst chain that has been repricing the wider silicon complex. We covered the AMD move through $1 trillion on the Muse launch, and what Meta actually shipped at Connect that set it off.
The problem with the price
Here is the part that most of the coverage has not confronted. Wall Street’s average 12-month price target for Intel is $116.37. The stock last traded at $127.39. The consensus target implies roughly 9% downside, not upside.
That is a genuinely unusual configuration, and it has a straightforward explanation: the share price has moved faster than analysts have revised. Consider the most bullish published target on the name. Tigress Financial raised its Intel target to $145 from $118, maintaining a Buy, citing stronger Xeon demand, solid 18A execution, expanding foundry opportunity and the Terafab partnership. At the time that target was set, Intel traded near $97, and $145 represented close to 50% upside. At $127.39 the same target represents about 14%.
Nothing about the Tigress thesis has been withdrawn. But an investor buying today is buying at a price that has already absorbed most of the gap the bull case was pointing at. The upgrades were the catalyst; the upgrades have now largely been paid for.
What could break the bid
Three things, in rough order of how quickly they could matter.
The fundamentals have not caught up to the narrative. Intel’s trailing EPS is -$2.17, reflecting a roughly $11.29 billion trailing net loss, and the most recent quarter carried a net loss near $11.0 billion against $7.0 billion of operating cash flow and $2.6 billion of capital expenditure. The forward P/E of 63.29 is built on an earnings recovery that has been forecast rather than delivered. A turnaround stock that has tripled is priced for that recovery arriving roughly on schedule.
The legacy business keeps shrinking underneath. Apple is now allowing Mac App Store developers to drop support for Intel-based Macs on apps requiring macOS 13 or later. In isolation this is small – Apple silicon has been the Mac default for years. But it is a reminder that while the AI inference story adds demand at one end, the structural erosion of Intel’s legacy x86 footprint continues at the other, and the second process is far more predictable than the first.
The move itself is unstable. Intel fell about 2.57% in regular trading on 24 September, immediately after a 9.1% surge in the prior session. Daily swings of that size in a $673 billion company are not the signature of a settled re-rating; they are the signature of a crowded, momentum-driven position. The session range alone – $119.55 to $127.43, nearly 7% – makes the point.
For contrast on what a fully-priced AI winner looks like when the market is calmer about it, see our note on the gap in the Microsoft AI rally. And for the macro forces that hit the whole chip complex earlier this week regardless of company news, see why Intel and AMD fell on oil and bond yields rather than on chips.
Scenarios
Unusually for a stock that has run this hard, the bear case here does not require inventing a level – it is the sell side’s own average target.
| Scenario | Level | vs $127.39 | What gets it there |
|---|---|---|---|
| Bear | $116.37 | -8.7% | Wall Street’s own average 12-month target. Momentum fades, the stock converges back to where analysts actually have it, and the loss-making trailing P&L reasserts itself. |
| Base | $127 – $142 | 0% to +11.7% | Inference demand holds up Xeon volumes, 18A stays on schedule, and the stock ranges between here and the 52-week high of $142.35 while earnings catch up. |
| Bull | $145 | +13.8% | Tigress Financial’s target (Buy, raised from $118): Xeon demand, 18A execution, foundry wins and operating leverage all land together. Note this target was set when INTC traded near $97. |
The asymmetry is worth stating plainly. The distance to the bull target is about 14%; the distance to the consensus target is about 9% in the other direction; and the distance back to the 52-week low is 75%. That does not make the bull case wrong – it means the easy part of this trade has already happened.
Quick Take
Intel’s AI inference thesis is credible and the 18A progress is real, which is why the stock is up more than 300% from its 52-week low. But at $127.39 it trades roughly 9% above Wall Street’s $116.37 average target, on trailing EPS of -$2.17 and a forward multiple above 60. The most bullish target on the Street, $145, was set when the shares were near $97. The re-rating has largely happened; what is left is execution risk at a price that assumes execution.
FAQ
Why is Intel stock up so much in 2026?
The move has been driven by a reassessment of Intel’s AI position. Demand for AI inference – particularly from consumer AI agents such as Meta’s Muse – has revived interest in server CPUs, where Intel’s Xeon line competes. Progress on the Intel 18A process and high-NA EUV manufacturing, reported PC processor price increases, and a series of analyst upgrades have compounded the move. The stock is up more than 300% from its 52-week low of $31.21.
What is Intel’s price target?
The average 12-month analyst target is $116.37, which is below the current price of $127.39 – implying about 9% downside on consensus. The most bullish named target is $145 from Tigress Financial, which maintains a Buy rating and raised the figure from $118, though that target was set when Intel traded near $97.
Is Intel profitable?
Not on a trailing basis. Intel’s trailing twelve-month EPS is -$2.17, reflecting a net loss of roughly $11.29 billion, and the most recent quarter carried a net loss near $11.0 billion. The company did generate about $7.0 billion of operating cash flow in the quarter against $2.6 billion of capital expenditure. The forward P/E of 63.29 is based on an expected earnings recovery rather than current profits.
How does Meta’s Muse affect Intel?
Muse is a consumer AI agent that topped the US free iPhone app chart for three consecutive days following its launch. Every task an AI agent performs consumes inference compute, and a meaningful share of inference serving runs on general-purpose server CPUs rather than accelerators. Rising agent usage therefore raises the demand baseline for Intel’s Xeon server processors – the mechanism behind the recent re-rating.
What is Intel 18A and why does it matter?
Intel 18A is the company’s advanced manufacturing process node. Reports indicate high-NA EUV lithography is now in high-volume manufacturing with over one million wafers run, and that Intel 18A and Panther Lake layers are performing at or above the prior 0.33 NA generation. Process execution was the central reason investors avoided Intel for years, so credible progress here is a material change to the investment case – and it underpins the foundry opportunity.
What are the main risks to Intel stock right now?
Three stand out: the trailing business is still loss-making while the forward multiple exceeds 60; Intel’s legacy x86 footprint continues to erode, with Apple now letting Mac App Store developers drop Intel Mac support for apps requiring macOS 13 or later; and the price action is volatile – a 9.1% surge followed immediately by a 2.57% decline suggests a crowded momentum position rather than a settled re-rating.
Is Intel stock a buy at $127?
That is a decision for each investor and their adviser, but the numbers frame it clearly: the consensus target sits about 9% below the current price, the most bullish published target is about 14% above it, and the shares have already risen more than 300% from their low. The upside case depends on earnings recovery arriving broadly on schedule. This article is information, not advice.
Sources: Yahoo Finance quote and consensus data (25 September 2026); Tigress Financial price target coverage via Benzinga and Investing.com; StocksToTrade and CoinCentral reporting on the Meta Muse and Apple Mac App Store developments; KeyBanc commentary attributed to analyst Justin Patterson.
Disclaimer: This article is for information purposes only and does not constitute financial or investment advice. FinanceFeeds does not recommend buying, selling or holding any security. Prices and analyst estimates cited were accurate at the time of writing and may since have changed. Trading and investing carry risk, including the loss of capital. Always conduct your own research and consider consulting a licensed financial adviser before making any investment decision.
